{
  "LinkTitle": "D-2023-2435",
  "Status": "Initial",
  "InitialDMPReviewStatus": "Reviewed",
  "Funder": "EU",
  "ProjectTitle": "Engineering viral vectors for high-throughput CRISPR genetic screens in plants",
  "InitialFeedbackHistory": "24/11/2023 [REDACTED] use of data repositories to make your data FAIR, I suggest that besides RDR you also look at repositories for the life sciences, as for some of your data types those will be more relevant. [REDACTED] already mention using GenBank further in your DMP, so make sure you indicate that each time you refer a repository to make data FAIR. [REDACTED] is also a data repository. [REDACTED] a look here for further relevant repositories: https://elixir-europe.org/platforms/data/elixir-deposition-databases and https://elixir-europe.org/platforms/data/core-data-resources [REDACTED] file naming convention you have a paragraph of text that has nothing to do with your research (oral histories, amnesty etc). [REDACTED] this. [REDACTED] here what you are already now applying in your research. [REDACTED] from your WPs is good. [REDACTED] [REDACTED] you first indicate that you will not share certain data due to contractual restrictions. [REDACTED] are those restrictions? [REDACTED] need to explain this. [REDACTED] this about valorization / IP by KU [REDACTED] or are there industry partners involved? [REDACTED] way, the EC is very clear in their requirements that it is mandatory for you to place all research data in data repositories, as open as possible, or with restricted access if needed. [REDACTED] their requirements here: https://www.kuleuven.be/rdm/en/guidance/funder#he [REDACTED] data that need a restriction also need to be in a data repository, with then information of how access can be requested.",
  "label": "good with suggestions"
}